The BCL2L11 (BIM) deletion polymorphism is a possible criterion for discontinuation of imatinib in chronic myeloid leukaemia patients
| Image |  |
|---|---|
| Description | scientific article published on 01 November 2012 |
| Author/s |
author: Tomohiro Umezu Seiichiro Katagiri |
| Publication date | November 1, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |